CADL
Price
$5.00
Change
+$0.11 (+2.25%)
Updated
Sep 5 closing price
Capitalization
274.48M
61 days until earnings call
INO
Price
$2.79
Change
+$0.04 (+1.45%)
Updated
Sep 5 closing price
Capitalization
148.27M
Interact to see
Advertisement

CADL vs INO

Header iconCADL vs INO Comparison
Open Charts CADL vs INOBanner chart's image
Candel Therapeutics
Price$5.00
Change+$0.11 (+2.25%)
Volume$941.03K
Capitalization274.48M
Inovio Pharmaceuticals
Price$2.79
Change+$0.04 (+1.45%)
Volume$1.66M
Capitalization148.27M
CADL vs INO Comparison Chart in %
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. INO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and INO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CADL: $5.00 vs. INO: $2.79)
Brand notoriety: CADL: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 114% vs. INO: 62%
Market capitalization -- CADL: $274.48M vs. INO: $148.27M
CADL [@Biotechnology] is valued at $274.48M. INO’s [@Biotechnology] market capitalization is $148.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, INO is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while INO’s TA Score has 5 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 4 bearish.
  • INO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INO is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а -13.64% price change this week, while INO (@Biotechnology) price change was +17.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

CADL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($274M) has a higher market cap than INO($148M). INO YTD gains are higher at: 56.742 vs. CADL (-42.396). CADL has higher annual earnings (EBITDA): -19.74M vs. INO (-84.73M). CADL has more cash in the bank: 101M vs. INO (47.5M). CADL has less debt than INO: CADL (8.34M) vs INO (10.7M). INO has higher revenues than CADL: INO (182K) vs CADL (0).
CADLINOCADL / INO
Capitalization274M148M185%
EBITDA-19.74M-84.73M23%
Gain YTD-42.39656.742-75%
P/E RatioN/AN/A-
Revenue0182K-
Total Cash101M47.5M213%
Total Debt8.34M10.7M78%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLINO
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 30 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABSCF1.26N/A
N/A
AB Science, Paris
ASXSF0.30N/A
N/A
Elysee Development Corp.
HOCPF126.95N/A
N/A
Hoya Corp.
VTSYF1.18N/A
N/A
Vitasoy International Holdings Ltd.
MYTEF1.64N/A
N/A
Telekom Malaysia Berhad

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RPTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+2.15%
RPTX - CADL
43%
Loosely correlated
N/A
INKT - CADL
34%
Loosely correlated
+7.64%
INO - CADL
33%
Poorly correlated
+1.45%
CELC - CADL
32%
Poorly correlated
+2.23%
NDTP - CADL
31%
Poorly correlated
N/A
More

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with KROS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+1.45%
KROS - INO
52%
Loosely correlated
+0.26%
RPTX - INO
51%
Loosely correlated
N/A
PCSA - INO
38%
Loosely correlated
+1.24%
OLMA - INO
35%
Loosely correlated
+30.87%
PGEN - INO
34%
Loosely correlated
-4.39%
More